Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
By failing to follow informed consent protocols and regulations, a researcher engaging in CBPR may inflict permanent harm on the participating community and chill future research among disadvantaged populations.
A new Virginia law governing collaborations between nurse practitioners and doctors leaves unresolved key legal issues in team-based care, including those pertaining to medical malpractice and liability and anticompetitive practices.
Krishna Lynch, RN, MJ, CPHRM and Rita F. Morris, RN, MJ
Court decisions on nurse liability draw a fine line between failing to take action in the patient’s best interest and advocating for patients in an uncollaborative manner.
An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in.